We are live on ! Find out more
GG

Gofen & Glossberg Portfolio holdings

AUM $3.89B
1-Year Est. Return 11.97%
This Fund
S&P 500
This Quarter Est. Return
+1.96%
1 Year Est. Return
-11.97%
3 Year Est. Return
+36.4%
5 Year Est. Return
+73.95%
10 Year Est. Return
AUM
$2.7B
AUM Growth
+$27.7M
Cap. Flow
-$7M
Cap. Flow %
-0.26%
Top 10 Hldgs %
24.54%
Holding
474
New
12
Increased
115
Reduced
195
Closed
19

Top Buys

Rank Stock Value
1
DD icon
DuPont de Nemours
DD
+$6.64M
2
MMM icon
3M
MMM
+$5.13M
3
CRM icon
Salesforce
CRM
+$4.32M
4
AMZN icon
Amazon
AMZN
+$3.46M
5
AVGO icon
Broadcom
AVGO
+$2.1M

Top Sells

Rank Stock Value
1
MON
Monsanto Co
MON
+$6.15M
2
GE icon
GE Aerospace
GE
+$3.4M
3
WFC icon
Wells Fargo
WFC
+$2.56M
4
IBM icon
IBM
IBM
+$2.39M
5
AGN
Allergan plc
AGN
+$1.76M

Sector Composition

Rank Sector Weight
1 Healthcare 14.59%
2 Financials 13.89%
3 Technology 12.64%
4 Industrials 11.12%
5 Consumer Staples 9.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NTRS icon
51
Northern Trust
NTRS
$22.4B
$16.8M 0.62%
163,504
+9,375
+6% +$993K
ABBV icon
52
AbbVie
ABBV
$455B
$16.4M 0.61%
176,580
-5,536
-3% -$541K
LMT icon
53
Lockheed Martin
LMT
$132B
$16.2M 0.6%
54,760
+2,443
+5% +$788K
HD icon
54
Home Depot
HD
$332B
$15.5M 0.58%
79,542
-878
-1% -$164K
EFA icon
55
iShares MSCI EAFE ETF
EFA
$78.5B
$15.3M 0.57%
228,270
+12,538
+6% +$879K
WFC icon
56
Wells Fargo
WFC
$258B
$14.9M 0.55%
269,046
-47,731
-15% -$2.56M
GILD icon
57
Gilead Sciences
GILD
$163B
$14.9M 0.55%
210,458
-3,897
-2% -$275K
IJR icon
58
iShares Core S&P Small-Cap ETF
IJR
$110B
$14.6M 0.54%
174,598
+2,578
+1% +$210K
VWO icon
59
Vanguard FTSE Emerging Markets ETF
VWO
$119B
$14.4M 0.53%
341,492
+11,933
+4% +$539K
UNP icon
60
Union Pacific
UNP
$172B
$14.1M 0.52%
99,840
+218
+0.2% +$30.4K
KSU
61
DELISTED
Kansas City Southern
KSU
$14.1M 0.52%
133,362
-100
-0.1% -$10.9K
TFC icon
62
Truist Financial
TFC
$63.5B
$13.9M 0.51%
274,763
+2,109
+0.8% +$112K
MET icon
63
MetLife
MET
$62.5B
$13.5M 0.5%
309,207
-35,727
-10% -$1.67M
IWR icon
64
iShares Russell Mid-Cap ETF
IWR
$56.1B
$12.6M 0.47%
237,772
-200
-0.1% -$10.5K
PM icon
65
Philip Morris
PM
$299B
$12.6M 0.47%
155,676
-1,431
-0.9% -$121K
FISV
66
Fiserv Inc
FISV
$28.8B
$12.2M 0.45%
164,650
-3,765
-2% -$273K
DE icon
67
Deere & Co
DE
$162B
$11.7M 0.43%
83,790
-600
-0.7% -$88.4K
GE icon
68
GE Aerospace
GE
$368B
$11.7M 0.43%
179,077
-50,937
-22% -$3.4M
CSCO icon
69
Cisco
CSCO
$448B
$11M 0.41%
255,244
+1,467
+0.6% +$64.1K
SCHW
70
Charles Schwab
SCHW
$181B
$11M 0.41%
214,621
+21,399
+11% +$1.19M
QCOM icon
71
Qualcomm
QCOM
$160B
$10.7M 0.4%
191,375
-11,835
-6% -$661K
EEM icon
72
iShares MSCI Emerging Markets ETF
EEM
$28.6B
$10.5M 0.39%
242,599
+2,172
+0.9% +$101K
LUX
73
DELISTED
Luxottica Group
LUX
$10.4M 0.39%
162,567
-1,045
-0.6% -$67.1K
T icon
74
AT&T
T
$159B
$10.1M 0.38%
418,384
+7,421
+2% +$186K
CL icon
75
Colgate-Palmolive
CL
$73.3B
$9.75M 0.36%
150,478
-2,664
-2% -$174K

Similar funds

Gofen & Glossberg's Q2 2018 Portfolio in Review

As of Q2 2018, Gofen & Glossberg held 474 positions worth $2.7B, up 1% from $2.67B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Gofen & Glossberg's Q2 2018 filing shows 12 new, 115 increased, 195 reduced and 19 closed positions. Its largest new stake was Evergy: 8,447 shares worth $474K. The largest sale was Monsanto Co, an estimated $6.15M.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 15% a quarter earlier, followed by Financials and Technology.

  • Gofen & Glossberg's largest Q2 2018 buy was Evergy: 8,447 shares worth $474K.
  • Gofen & Glossberg added most to DuPont de Nemours in Q2 2018, an estimated $6.64M increase.
  • Gofen & Glossberg's biggest Q2 2018 reduction was GE Aerospace, cutting an estimated $3.4M.
  • Gofen & Glossberg fully exited Monsanto Co in Q2 2018, selling an estimated $6.15M.
  • Gofen & Glossberg's ten largest holdings make up 25% of its $2.7B portfolio in Q2 2018.
  • Gofen & Glossberg opened 12 new positions and closed 19 in Q2 2018.
  • Gofen & Glossberg's portfolio value rose 1% quarter-over-quarter to $2.7B.

Based on Gofen & Glossberg's 13F filing for Q2 2018, filed 11 Jul 2018.